Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer: 7-year results of PRODIGE 23 phase III trial, a UNICANCER GI trial.
ANNÉE
2023
AUTEURS
Conroy T, Etienne PL, Rio E, Evesque L, Mesgouez-Nebout N, Vendrely V, Artignan X, Bouche O, Boileve A, Delaye M, Gargot D, Boige V, Bonichon-Lamichhane N, Louvet C, De La Fouchardiere C, Morand C, Pezzella V, Rullier E, Castan F, and BorgC
CONGRÈS/REVUE
ASCO
LIEN PUBLICATIONS ASSOCIÉES